Closed Clinical Trials

The table below contains a list of all ECOG-ACRIN clinical trials that have closed to enrollment since January 1, 2021. Note that this is not a complete listing of all closed trials. On the table below, hover over any of the column headings and click the up/down arrows to sort. You can also search by keyword. To access more information about a particular trial, click on the trial ID, which will link you to more information.



Cancer TypeTarget patient PopulationTrial ID & Link to infoStudy Type ECOG-ACRIN Oversight Committee(s)
VariousMetastatic (advanced) solid tumors, lymphomas, or myeloma and also rare cancer types with no standard treatment availableEAY131 / NCI-MATCHTreatmentDevelopmental Therapeutics
AnyWomen with a recent cancer diagnosis E1Q11 / EROS Reproductive Health PlanningCancer Control and Survivorship
AnyCurrent smokers wanting to stopEAQ171CDObservation (Counseling)Cancer Care Delivery Research
AnusMetastatic (advanced)EA2165TreatmentGastrointestinal
BloodAcute promyelocytic leukemia (AML)EA9131TreatmentLeukemia; Cancer Control and Survivorship
Blood Chronic lymphocytic leukemia (CLL)EA9161TreatmentLeukemia
BreastNewly diagnosed, metastatic (advanced)EAI142ImagingBreast
BreastBlack women with breast cancerEAZ171TreatmentBreast; Prevention
BreastWomen who decline the TMIST breast cancer screening trialEAQ201Observation (Patient Reporting))Cancer Control and Survivorship
BreastTriple negative and basal subtype, including both women and menEA1131TreatmentBreast
KidneyLocalized (no spread) or limited spreadEA8143 / PROSPER RCCTreatmentGenitourinary
Melanoma (Skin)Melanoma, metastatic (advanced), and BRAF V600 typeEA6134 / DREAMseqTreatmentMelanoma
Melanoma (Skin)Cutaneous or unknown primary typeEA6183TreatmentMelanoma
Pancreas or Gastrointestinal TractLocally advanced or metastatic, inoperableEA2142TreatmentGastrointestinal
ProstateMetastatic (advanced), hormone sensitive typeEA8153 / CHAARTED2TreatmentGenitourinary
ECOG-ACRIN Cancer Research Group